PainNCT07737392
Lavender Sandalwood Aromatherapy Study
A study testing Lavender-sandalwood aromatherapy tabs in people with Pain and Mood, run by Memorial Hermann Health System at 1 site in United States.
Trial summary
The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Pain, Mood, Patient Satisfaction
- What is being tested?
- Lavender-sandalwood aromatherapy tabs
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 182 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2026to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients scheduled for a planned cesarean section
- Undergoing pre-admission testing
Who cannot join
- Individuals under 18 years of age
- High-risk pregnancies
- Patients not admitted to the postpartum unit following delivery
- Individuals with known allergies to essential oils
- Patients whose newborns require admission to the NICU
- Patients originally scheduled for a cesarean section but admitted to the labor and delivery unit before the planned procedure
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Memorial Hermann Memorial City Medical Center
Houston, Texas, 77024
About this study
Official title: Does Aromatherapy Improve Mood and Reduce Pain in Women After Scheduled Cesarean Procedures?
The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. The main questions this study aims to answer are:
- How does lavender sandalwood aromatherapy affect participants' mood during postpartum recovery after a cesarean section?
- Does lavender sandalwood aromatherapy help reduce pain during recovery?
- Does lavender sandalwood aromatherapy improve participants' overall satisfaction with their recovery experience? Researchers will compare participants who receive lavender-sandalwood aromatherapy with those who do not to determine whether it improves mood, reduces pain, and enhances patient satisfaction.
Read more
Participants will be asked to:
- Wear aromatherapy tabs on their gown for 24 hours.
- Have the aromatherapy tabs applied 24 hours after the cesarean section and removed 48 hours after the cesarean section.
- Complete surveys at 24 hours and 48 hours after the cesarean section. This will apply to both the control and intervention groups.
Read the detailed description
Aromatherapy represents a holistic, patient-centered approach designed to enhance comfort, relaxation, and sleep for individuals receiving medical care. This method is both cost-effective and associated with minimal side effects, making it an appealing option as a complementary therapy. For centuries, essential oils have been incorporated into care routines to help relieve a variety of symptoms, including pain, anxiety, stress, and insomnia. Their use is especially prominent during significant life events such as pregnancy, labor, and the postpartum period, where they support emotional and physical well-being.
This randomized controlled trial has been designed to assess the therapeutic effects of Lavender Sandalwood Elequil Aromatabs in women scheduled for planned cesarean sections. In this study, participants in the experimental group will receive self-adhesive aromatherapy tabs containing a blend of lavender and sandalwood essential oils. These tabs are conveniently placed on hospital gowns and are intended to deliver continuous aromatic benefits for up to 24 hours following surgery, in addition to the standard post-operative care provided. Participants in the control group, on the other hand, will receive only the standard care without aromatherapy exposure.
The primary objectives of this study are to evaluate changes in emotional well-being, pain perception, and overall patient satisfaction among cesarean-section patients. Emotional states will be measured using the Positive and Negative Affect Schedule (PANAS), which captures both positive and negative mood dimensions. Pain levels will be assessed with the Defense Veterans Pain Rating Scale (DVPRS), a validated tool for quantifying pain intensity. Additionally, the Net Promoter Score (NPS) will be used to gauge patient satisfaction with their care experience. Collectively, these measures will offer comprehensive insights into how aromatherapy may contribute to improved recovery and holistic well-being during the post-surgical period.
- Conditions
- Pain, Mood, Patient Satisfaction, Scheduled Cesarean Sections
- Being tested
- Lavender-sandalwood aromatherapy tabs
- Keywords
- Post C/section, Pain, Mood, Aromatherapy, Lavender, Sandalwood, Patient satisfaction
- Medical subject headings
- Pain, Patient Satisfaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lavender-sandalwood aromatherapy tabsOther
The intervention used in this study consists of aromatherapy tabs infused with lavender and sandalwood essential oils. These aromatabs are administered to participants following their cesarean section procedures to evaluate their effectiveness in managing postoperative pain. The choice of lavender and sandalwood is based on their widely recognized calming and analgesic properties, with the goal of providing non-pharmacological support for pain relief. Participants in the experimental group will receive these aromatabs according to the study protocol, allowing for a clear comparison of outcomes between the aromatherapy intervention and the control group.
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | Participants assigned to the control group will receive standard post-operative care following their scheduled cesarean section, with no aromatherapy intervention. This approach enables a clear comparison with the experimental group to evaluate the impact of aromatherapy. The PANAS and DVPRS assessments will be administered at 24 and 48 hours post-surgery. |
| Experimental group | Experimental | Participants assigned to the intervention group will have self-adhesive aromatherapy tabs applied to their hospital gowns within 24 hours after their cesarean surgery. These aromatabs, containing a blend of lavender and sandalwood essential oils, are worn continuously for 24 hours, delivering consistent aromatic exposure. After this 24-hour interval, the tabs will be removed 48 hours post-surgery. To assess the impact of the aromatherapy intervention, the Positive and Negative Affect Schedule (PANAS) and the Defense Veterans Pain Rating Scale (DVPRS) will be administered at both the 24-hour and 48-hour following surgery. This approach will allow for a detailed evaluation of changes in mood and pain levels associated with the use of Aromatabs during the immediate postoperative recovery period. Receives: Other: Lavender-sandalwood aromatherapy tabs |
What is being measured
The primary outcome is the main question the study is designed to answer.
PANAS survey to measure mood
The primary outcome of this study focuses on evaluating participants' emotional well-being by utilizing the Positive and Negative Affect Schedule (PANAS). This assessment tool will be administered twice: first, at the baseline 24 hours after delivery, and then again at 48 hours following surgery. By comparing PANAS results from these two time points, the study aims to capture any changes in both positive and negative mood dimensions that may occur as a result of the intervention. This approach provides a comprehensive analysis of how the aromatherapy tabs may influence mood and emotional states during the immediate postoperative recovery period.
Measured: The period begins when you enroll and ends when you are discharged, and usually covers a timeframe of three to six days.
Secondary outcomes (1)
DVPRS to Measure Pain and Patient Satisfaction
Pain assessment will use the Defense and Veterans Pain Rating Scale (DVPRS) at two intervals-around 24 hours after cesarean section (±4 hours), and at 48 hours post-surgery or before hospital discharge (within a 4-hour window, or at the last pain score before discharge if earlier). This method evaluates the effectiveness of aromatherapy in both control and experimental groups.
Measured: The period begins when the participants enroll and ends when they are discharged, and usually covers a timeframe of three to six days.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2026
- Study startSep 2026 (estimated)
- Primary completionAug 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 182 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Memorial Hermann Health System
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mi Park, Memorial Hermann Health System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07737392
- Sponsor's protocol ID
- HSC-MH-25-0731
- Status last verified
- Jul 2026
- First submitted
- 27 Jul 2026
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified participant data supporting published findings may be shared after publication to support transparency, reproducibility, and privacy protection. Shared data may include de-identified mood, pain, satisfaction, intervention assignment, survey timing, and relevant baseline or perioperative variables.
Publications
Hedigan F, Sheridan H, Sasse A. Benefit of inhalation aromatherapy as a complementary treatment for stress and anxiety in a clinical setting - A systematic review. Complement Ther Clin Pract. 2023 Aug;52:101750. doi: 10.1016/j.ctcp.2023.101750. Epub 2023 Apr 5.
PubMed 37031643Lin PH, Lin YP, Chen KL, Yang SY, Shih YH, Wang PY. Effect of aromatherapy on autonomic nervous system regulation with treadmill exercise-induced stress among adolescents. PLoS One. 2021 Apr 13;16(4):e0249795. doi: 10.1371/journal.pone.0249795. eCollection 2021.
PubMed 33848307Vora LK, Gholap AD, Hatvate NT, Naren P, Khan S, Chavda VP, Balar PC, Gandhi J, Khatri DK. Essential oils for clinical aromatherapy: A comprehensive review. J Ethnopharmacol. 2024 Aug 10;330:118180. doi: 10.1016/j.jep.2024.118180. Epub 2024 Apr 16.
PubMed 38614262Tabatabaeichehr M, Mortazavi H. The Effectiveness of Aromatherapy in the Management of Labor Pain and Anxiety: A Systematic Review. Ethiop J Health Sci. 2020 May;30(3):449-458. doi: 10.4314/ejhs.v30i3.16.
PubMed 32874088Hadi N, Hanid AA. Lavender essence for post-cesarean pain. Pak J Biol Sci. 2011 Jun 1;14(11):664-7. doi: 10.3923/pjbs.2011.664.667.
PubMed 22235509Caballero-Gallardo K, Quintero-Rincon P, Olivero-Verbel J. Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing. Plants (Basel). 2025 Jan 29;14(3):400. doi: 10.3390/plants14030400.
PubMed 39942962Blackburn LM, Burns K, DiGiannantoni E, Meade K, O'Leary C, Stiles R. Pain Assessment: Use of the Defense and Veterans Pain Rating Scale in Patients With Cancer. Clin J Oncol Nurs. 2018 Dec 1;22(6):643-648. doi: 10.1188/18.CJON.643-648.
PubMed 30451995Bertone AC, Dekker RL. Aromatherapy in Obstetrics: A Critical Review of the Literature. Clin Obstet Gynecol. 2021 Sep 1;64(3):572-588. doi: 10.1097/GRF.0000000000000622.
PubMed 33927109Beekley Medical (2025). Elequil aromatabs: Aromatherapy designed for the clinical setting. Retrieved from https://beekley.com/clinical-aromatherapy/elequil-aromatabs-aromatherapy-designedfor-the-clinical-setting
Ali, B., Al-Wabel, N. A., Shams, S., Ahamad, A., Khan, S. A., & Anwar, F. (2015). Essential oils used in aromatherapy: A systemic review. Asian Pacific Journal of Tropical Biomedicine, 5(8), 601-611. https://doi.org/10.1016/j.apjtb.2015.05.007
Positive Psychology.com. (2019). What is the positive and negative affection schedule? Retrieved from https://positivepsychology.com/positive-and-negative-affect-schedule-panas/
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Aromatherapy Improve Mood and Reduce Pain in Women After Scheduled Cesarean Procedures?
- ClinicalTrials.gov ID
- NCT07737392
- Acronym / sponsor ID
- HSC-MH-25-0731
- Conditions
- Pain, Mood, Patient Satisfaction, Scheduled Cesarean Sections
- Keywords
- Post C/section, Pain, Mood, Aromatherapy, Lavender, Sandalwood, Patient satisfaction
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 182 participants (estimated)
- Lead sponsor
- Memorial Hermann Health SystemUniversity, hospital or other
- Study start
- Sep 2026 (estimated)
- Primary completion
- Aug 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 30 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. The main questions this study aims to answer are:
- How does lavender sandalwood aromatherapy affect participants' mood during postpartum recovery after a cesarean section?
- Does lavender sandalwood aromatherapy help reduce pain during recovery?
- Does lavender sandalwood aromatherapy improve participants' overall satisfaction with their recovery experience? Researchers will compare participants who receive lavender-sandalwood aromatherapy with those who do not to determine whether it improves mood, reduces pain, and enhances patient satisfaction.
Participants will be asked to:
- Wear aromatherapy tabs on their gown for 24 hours.
- Have the aromatherapy tabs applied 24 hours after the cesarean section and removed 48 hours after the cesarean section.
- Complete surveys at 24 hours and 48 hours after the cesarean section. This will apply to both the control and intervention groups.
Detailed description
Aromatherapy represents a holistic, patient-centered approach designed to enhance comfort, relaxation, and sleep for individuals receiving medical care. This method is both cost-effective and associated with minimal side effects, making it an appealing option as a complementary therapy. For centuries, essential oils have been incorporated into care routines to help relieve a variety of symptoms, including pain, anxiety, stress, and insomnia. Their use is especially prominent during significant life events such as pregnancy, labor, and the postpartum period, where they support emotional and physical well-being.
This randomized controlled trial has been designed to assess the therapeutic effects of Lavender Sandalwood Elequil Aromatabs in women scheduled for planned cesarean sections. In this study, participants in the experimental group will receive self-adhesive aromatherapy tabs containing a blend of lavender and sandalwood essential oils. These tabs are conveniently placed on hospital gowns and are intended to deliver continuous aromatic benefits for up to 24 hours following surgery, in addition to the standard post-operative care provided. Participants in the control group, on the other hand, will receive only the standard care without aromatherapy exposure.
The primary objectives of this study are to evaluate changes in emotional well-being, pain perception, and overall patient satisfaction among cesarean-section patients. Emotional states will be measured using the Positive and Negative Affect Schedule (PANAS), which captures both positive and negative mood dimensions. Pain levels will be assessed with the Defense Veterans Pain Rating Scale (DVPRS), a validated tool for quantifying pain intensity. Additionally, the Net Promoter Score (NPS) will be used to gauge patient satisfaction with their care experience. Collectively, these measures will offer comprehensive insights into how aromatherapy may contribute to improved recovery and holistic well-being during the post-surgical period.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –Participants assigned to the control group will receive standard post-operative care following their scheduled cesarean section, with no aromatherapy intervention. This approach enables a clear comparison with the experimental group to evaluate the impact of aromatherapy. The PANAS and DVPRS assessments will be administered at 24 and 48 hours post-surgery. |
| Experimental group | Experimental | Other: Lavender-sandalwood aromatherapy tabsParticipants assigned to the intervention group will have self-adhesive aromatherapy tabs applied to their hospital gowns within 24 hours after their cesarean surgery. These aromatabs, containing a blend of lavender and sandalwood essential oils, are worn continuously for 24 hours, delivering consistent aromatic exposure. After this 24-hour interval, the tabs will be removed 48 hours post-surgery. To assess the impact of the aromatherapy intervention, the Positive and Negative Affect Schedule (PANAS) and the Defense Veterans Pain Rating Scale (DVPRS) will be administered at both the 24-hour and 48-hour following surgery. This approach will allow for a detailed evaluation of changes in mood and pain levels associated with the use of Aromatabs during the immediate postoperative recovery period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Patients scheduled for a planned cesarean section
- Undergoing pre-admission testing
Key exclusion criteria (6 listed)
- Individuals under 18 years of age
- High-risk pregnancies
- Patients not admitted to the postpartum unit following delivery
- Individuals with known allergies to essential oils
- Patients whose newborns require admission to the NICU
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lavender-sandalwood aromatherapy tabsThe intervention used in this study consists of aromatherapy tabs infused with lavender and sandalwood essential oils. These aromatabs are administered to participants following their cesarean section procedures to evaluate their effectiveness in managing postoperative pain. The choice of lavender and sandalwood is based on their widely recognized calming and analgesic properties, with the goal of providing non-pharmacological support for pain relief. Participants in the experimental group will receive these aromatabs according to the study protocol, allowing for a clear comparison of outcomes between the aromatherapy intervention and the control group. | Other | Experimental group |
Primary outcome
PANAS survey to measure mood
Time frame: The period begins when you enroll and ends when you are discharged, and usually covers a timeframe of three to six days.
The primary outcome of this study focuses on evaluating participants' emotional well-being by utilizing the Positive and Negative Affect Schedule (PANAS). This assessment tool will be administered twice: first, at the baseline 24 hours after delivery, and then again at 48 hours following surgery. By comparing PANAS results from these two time points, the study aims to capture any changes in both positive and negative mood dimensions that may occur as a result of the intervention. This approach provides a comprehensive analysis of how the aromatherapy tabs may influence mood and emotional states during the immediate postoperative recovery period.
1 secondary outcome
DVPRS to Measure Pain and Patient Satisfaction
Time frame: The period begins when the participants enroll and ends when they are discharged, and usually covers a timeframe of three to six days.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2026.
- Background: PubMed 37031643Hedigan F, Sheridan H, Sasse A. Benefit of inhalation aromatherapy as a complementary treatment for stress and anxiety in a clinical setting - A systematic review. Complement Ther Clin Pract. 2023 Aug;52:101750. doi: 10.1016/j.ctcp.2023.101750. Epub 2023 Apr 5.
- Background: PubMed 33848307Lin PH, Lin YP, Chen KL, Yang SY, Shih YH, Wang PY. Effect of aromatherapy on autonomic nervous system regulation with treadmill exercise-induced stress among adolescents. PLoS One. 2021 Apr 13;16(4):e0249795. doi: 10.1371/journal.pone.0249795. eCollection 2021.
- Background: PubMed 38614262Vora LK, Gholap AD, Hatvate NT, Naren P, Khan S, Chavda VP, Balar PC, Gandhi J, Khatri DK. Essential oils for clinical aromatherapy: A comprehensive review. J Ethnopharmacol. 2024 Aug 10;330:118180. doi: 10.1016/j.jep.2024.118180. Epub 2024 Apr 16.
- Background: PubMed 32874088Tabatabaeichehr M, Mortazavi H. The Effectiveness of Aromatherapy in the Management of Labor Pain and Anxiety: A Systematic Review. Ethiop J Health Sci. 2020 May;30(3):449-458. doi: 10.4314/ejhs.v30i3.16.
- Background: PubMed 22235509Hadi N, Hanid AA. Lavender essence for post-cesarean pain. Pak J Biol Sci. 2011 Jun 1;14(11):664-7. doi: 10.3923/pjbs.2011.664.667.
- Background: PubMed 39942962Caballero-Gallardo K, Quintero-Rincon P, Olivero-Verbel J. Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing. Plants (Basel). 2025 Jan 29;14(3):400. doi: 10.3390/plants14030400.
- Background: PubMed 30451995Blackburn LM, Burns K, DiGiannantoni E, Meade K, O'Leary C, Stiles R. Pain Assessment: Use of the Defense and Veterans Pain Rating Scale in Patients With Cancer. Clin J Oncol Nurs. 2018 Dec 1;22(6):643-648. doi: 10.1188/18.CJON.643-648.
- Background: PubMed 33927109Bertone AC, Dekker RL. Aromatherapy in Obstetrics: A Critical Review of the Literature. Clin Obstet Gynecol. 2021 Sep 1;64(3):572-588. doi: 10.1097/GRF.0000000000000622.
- BackgroundBeekley Medical (2025). Elequil aromatabs: Aromatherapy designed for the clinical setting. Retrieved from https://beekley.com/clinical-aromatherapy/elequil-aromatabs-aromatherapy-designedfor-the-clinical-setting
- BackgroundAli, B., Al-Wabel, N. A., Shams, S., Ahamad, A., Khan, S. A., & Anwar, F. (2015). Essential oils used in aromatherapy: A systemic review. Asian Pacific Journal of Tropical Biomedicine, 5(8), 601-611. https://doi.org/10.1016/j.apjtb.2015.05.007
- Results publicationPositive Psychology.com. (2019). What is the positive and negative affection schedule? Retrieved from https://positivepsychology.com/positive-and-negative-affect-schedule-panas/
- Individual participant dataSharing planned: Yes. De-identified participant data supporting published findings may be shared after publication to support transparency, reproducibility, and privacy protection. Shared data may include de-identified mood, pain, satisfaction, intervention assignment, survey timing, and relevant baseline or perioperative variables.
Related trials for Pain
Not yet recruiting
Effects of Adding Vagal Neuromodulation to Manual Therapy in Women With Fibromyalgia
Fibromyalgia (FM) OR Fibromyalgia Syndrome, Manuel Therapy
Not yet recruitingPhase 3
Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT
Chronic Low Back Pain, Musculoskeletal Pain
Not yet recruiting
Testing the Timing and Application of Virtual Reality Distraction During Knee Injections in a VA Pain Clinic
Pain Management, Injection Pain Prevention
Not yet recruiting
The Effect of a Ginger Formula on Menstrual Health vs a Placebo
Painful Menstruation
Not yet recruitingEarly Phase 1
Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder
Opioid Use Disorder, Alcohol Intoxication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Lavender-sandalwood aromatherapy tabs in people with Pain and Mood, run by Memorial Hermann Health System at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mi Y Park, MSN (18322476717, mi.park@memorialhermann.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
PANAS survey to measure mood (time frame: The period begins when you enroll and ends when you are discharged, and usually covers a timeframe of three to six days.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07737392, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.